Stay updated on Ganaxolone in PCDH19 Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.

Latest updates to the Ganaxolone in PCDH19 Epilepsy Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice appears announcing updates and FAQs about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, signaling an access restriction rather than an update to the study details.SummaryDifference17%

- Check58 days agoChange DetectedRevision indicates the platform was updated from v3.6.5 to v3.6.6, a minor version bump. This update does not alter study data, eligibility criteria, or other core content on the page.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5, indicating a new build/deployment. No visible content or functionality changes were made.SummaryDifference0.1%

Stay in the know with updates to Ganaxolone in PCDH19 Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ganaxolone in PCDH19 Epilepsy Clinical Trial page.